The global Polyclonal Antibodies Market is entering a phase of steady, technology-driven expansion. Valued at approximately USD 1.17 billion in 2024, the market is projected to reach USD 1.83 billion by 2032, progressing at a Compound Annual Growth Rate (CAGR) of 5.70% during the forecast period from 2025 to 2032. Polyclonal antibodies (pAbs) are a heterogeneous mixture of immunoglob... https://www.databridgemarketresearch.com/reports/global-polyclonal-antibodies-market